Controlling body announces approval for increased shelf life of Epiprotect
The Company’s notified body has announced that increased shelf life, from 1 to 3 years, for the products in the Epiprotect series is approved. The approval was obtained after audit of necessary tests and documentation. ECM is the Company’s notified body and is in accordance with the EU directive for medical devices, responsible for the Company’s compliance of the rules of the directive. As previously announced, the products in the Epiprotect-series have received CE-mark after approval of ECM. The Company has performed all necessary tests to further increase the shelf life to